XML 32 R22.htm IDEA: XBRL DOCUMENT v3.22.2
Business Segment
 6 Months Ended
Jun. 30, 2022
Segment Reporting [Abstract]  
Business Segment Business Segment
We are accounting and reporting for our business as a single operating segment entity engaged in the development, manufacturing and sale on a global basis of surgical devices and related equipment. Our chief operating decision maker (the CEO) evaluates the various global product portfolios on a net sales basis and evaluates profitability, investment, cash flow metrics and allocates resources on a consolidated worldwide basis due to shared infrastructure and resources. Our product lines consist of orthopedic surgery and general surgery. Orthopedic surgery consists of sports medicine instrumentation and small bone, large bone and specialty powered surgical instruments as well as imaging systems for use in minimally invasive surgery procedures and fees related to the sales representation, promotion and marketing of sports medicine allograft tissue. General surgery consists of a complete line of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, smoke evacuation devices, a line of cardiac monitoring products as well as electrosurgical generators and related instruments. These product lines' net sales are as follows:

Three Months Ended June 30,Six Months Ended June 30,
 2022202120222021
Orthopedic surgery$120,182 $107,893 $227,698 $215,058 
General surgery157,008 147,268 291,818 272,779 
Consolidated net sales$277,190 $255,161 $519,516 $487,837